P&T Heart Failure

MMIT recently conducted a syndicated simulated P&T Heart Failure session focused on the entry Farxiga, and anticipated entry of Jardiance, into heart failure.

Learn how you can use P&T Perspectives to:

• Gain an understanding of the impact of these agents in heart failure and how that might impact your brand.
• Boost your brand by identifying the key differentiators and any unforeseen access barriers